We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Thiogenesis Therapeutics Corp | TSXV:TTI | TSX Venture | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.70 | 0.69 | 0.71 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
VANCOUVER, Nov. 6, 2012 /CNW/ -
BULLETIN TYPE: Cease Trade Order
BULLETIN DATE: November 6, 2012
TSX Venture Company
A Cease Trade Order has been issued by the British Columbia Securities Commission on November 6, 2012 against the following company for failing to file the documents indicated within the required time period:
| Symbol | Tier | Company | Failure to File |
Period Ending (Y/M/D) |
|
TTI |
2 |
TransGlobe Internet and Telecom Co., Ltd. |
Interim financial statements for the financial period ended |
2012/08/31 |
|
|
|
|
A Form 51-102F1 Management's Discussion and Analysis for the period ended |
2012/08/31 |
Upon revocation of the Cease Trade Order, the company's shares will remain suspended until the company meets TSX Venture Exchange requirements. Members are prohibited from trading in the securities of the company during the period of the suspension or until further notice.
________________________________________
SOURCE TSX Venture Exchange
Copyright 2012 Canada NewsWire
1 Year Thiogenesis Therapeutics Chart |
1 Month Thiogenesis Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
